The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G.
Name: Naltrexone
Description: 380mg extended-release, given once by intramuscular gluteal injectionType: DrugA118G Wild-type
Allocation: Non-Randomized
Parallel Assignment
There is one SNP
A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP. --- A118G ---
The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G. --- A118G ---
The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G. --- A118G --- --- A118G ---